Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis

European Heart Journal

Volumn 38, Issue 24, 2017, Pages 1905-1908

  Quarta, Candida Cristina ^a,b   Gonzalez Lopez, Esther ^c   Gilbertson, Janet A ^a   Botcher, Nichola ^a   Rowczenio, Dorota ^a   Petrie, Aviva ^d   Rezk, Tamer ^a   Youngstein, Taryn ^a   Mahmood, Shameem ^a   Sachchithanantham, Sajitha ^a   Lachmann, Helen J ^a   Fontana, Marianna ^a   Whelan, Carol J ^a   Wechalekar, Ashutosh D ^a   Hawkins, Philip N ^a   Gillmore, Julian D ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Amyloid; Amyloidosis; Cardiomyopathy; Diagnosis; Fat aspiration; Scintigraphy

Indexed keywords

CONGO RED; PREALBUMIN; SERUM AMYLOID P; RADIOACTIVE IODINE;

ABDOMINAL FAT; AGED; AL AMYLOIDOSIS; ARTICLE; FINE NEEDLE ASPIRATION BIOPSY; HEART AMYLOIDOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCINTIGRAPHY; AMYLOIDOSIS; CARDIOMYOPATHY; EVALUATION STUDY; FAMILIAL AMYLOID POLYNEUROPATHY; FEMALE; MALE; PATHOLOGY; PROCEDURES; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

ABDOMINAL FAT; AGED; AMYLOID NEUROPATHIES, FAMILIAL; AMYLOIDOSIS; BIOPSY, FINE-NEEDLE; CARDIOMYOPATHIES; CONGO RED; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; RADIONUCLIDE IMAGING; SENSITIVITY AND SPECIFICITY; SERUM AMYLOID P-COMPONENT;

EID: 85021310899     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehx047     Document Type: Article

References (23)

1. Arapakis G, Tribe CR. Amyloidosis in rheumatoid arthritis investigated by means of rectal biopsy. Ann Rheum Dis 1963; 22: 256-262.
2. Kyle RA, Spencer RJ, Dahlin DC. Value of rectal biopsy in the diagnosis of primary systemic amyloidosis. Am J Med Sci 1966; 251: 501-506.
3. Hachulla E, Janin A, Marc Flipo R, Säle R, Facon T, Bataille D, Vanhille P, Hatron PY, Devulder B, Duquesnoy B. Labial salivary gland biopsy is a reliable test for the diagnosis of primary and secondary amyloidosis. A prospective clinical immunohistologic study in 59 patients. Arthritis Rheum 1993; 36: 691-697.
4. Ansari-Lari MA, Ali SZ. Fine-needle aspiration of abdominal fat pad for amyloid detection: a clinically useful test. Diagn Cytopathol 2004; 30: 178-181.
5. Maurer MS. Noninvasive identification of ATTRwt cardiac amyloid: the reemergence of nuclear cardiology. Am J Med 2015; 128: 1275-1280.
6. Kyle RA, Greipp PR. Amyloidosis (AL): clinical and laboratory features in 229 cases. Mayo Clin Proc 1983; 58: 665-683.
7. Wechalekar AD, Schonland SO, Kastritis E, Gillmore JD, Dimopoulos MA, Lane T, Foli A, Foard D, Milani P, Rannigan L, Hegenbart U, Hawkins PN, Merlini G, Palladini G. A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis. Blood 2013; 121: 3420-3427.
8. Jacobson DR, Pastore RD, Yaghoubian R, Kane I, Gallo G, Buck FS, Buxbaum JN. Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans. N Engl J Med 1997; 336: 466-473.
9. Pinney JH, Whelan CJ, Petrie A, Dungu J, Banypersad SM, Sattianayagam P, Wechalekar A, Gibbs SD, Venner CP, Wassef N, McCarthy CA, Gilbertson JA, Rowczenio D, Hawkins PN, Gillmore JD, Lachmann HJ. Senile systemic amyloidosis: clinical features at presentation and outcome. J Am Heart Assoc 2013; 2: e000098.
10. Mohammed SF, Mirzoyev SA, Edwards WD, Dogan A, Grogan DR, Dunlay SM, Roger VL, Gertz MA, Dispenzieri A, Zeldenrust SR, Redfield MM. Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction. JACC Heart Fail 2014; 2: 113-122.
11. Bijzet J, Van Gameren II, Hazenberg BP, Fat tissue analysis in the management of patients with systemic amyloidosis. In: MM Picken, A., Dogan, G. A., Herrera, editors. Amyloid and Related Disorders: Surgical Pathology and Clinical Correlations. New York: Humana Press; 2012. p191-207.
12. Fine NM, Arruda-Olson AM, Dispenzieri A, Zeldenrust SR, Gertz MA, Kyle RA, Swiecicki PL, Scott CG, Grogan M. Yield of noncardiac biopsy for the diagnosis of transthyretin cardiac amyloidosis. Am J Cardiol 2014; 113: 1723-1177.
13. van G, II, Hazenberg BP, Bijzet J, van Rijswijk MH. Diagnostic accuracy of subcutaneous abdominal fat tissue aspiration for detecting systemic amyloidosis and its utility in clinical practice. Arthritis Rheum 2006; 54: 2015-2021.
14. Hawkins PN, Lavender JP, Pepys MB. Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component. N Engl J Med 1990; 323: 508-513.
15. Rapezzi C, Quarta CC, Guidalotti PL, Longhi S, Pettinato C, Leone O, Ferlini A, Salvi F, Gallo P, Gagliardi C, Branzi A, Perugini E. Usefulness and limitations of 99mTc-3, 3-diphosphono-1, 2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy. Eur J Nucl Med Mol Imaging 2011; 38: 470-478.
16. Rowczenio DM, Noor I, Gillmore JD, Lachmann HJ, Whelan C, Hawkins PN, Obici L, Westermark P, Grateau G, Wechalekar AD. Online registry for mutations in hereditary amyloidosis including nomenclature recommendations. Hum Mutat 2014; 35: E2403-E2412.
17. Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, Wechalekar AD, Berk JL, Quarta CC, Grogan M, Lachmann HJ, Bokhari S, Castano A, Dorbala S, Johnson GB, Glaudemans AW, Rezk T, Fontana M, Palladini G, Milani P, Guidalotti PL, Flatman K, Lane T, Vonberg FW, Whelan CJ, Moon JC, Ruberg FL, Miller EJ, Hutt DF, Hazenberg BP, Rapezzi C, Hawkins PN. Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis. Circulation 2016; 133: 2404-2412.
18. Tennent GA, Cafferty KD, Pepys MB, Hawkins PN, Congo red overlay immunohistochemistry aids classification of amyloid deposits. In: RA Kyle, MA Gertz, editors. Amyloid and Amyloidosis 1998. Pearl River, New York: Parthenon Publishing; 1999. p. 160-162.
19. Hawkins PN, Pepys MB. Imaging amyloidosis with radiolabelled SAP. Eur J Nucl Med 1995; 22: 595-599.
20. Rydh A, Suhr O, Hietala S-O, åhlström KR, Pepys MB, Hawkins PN. Serum amyloid P component scintigraphy in familial amyloid polyneuropathy: regression of visceral amyloid following liver transplantation. Eur J Nucl Med 1998; 25: 709-713.
21. Sattianayagam PT, Hahn AF, Whelan CJ, Gibbs SD, Pinney JH, Stangou AJ, Rowczenio D, Pflugfelder PW, Fox Z, Lachmann HJ, Wechalekar AD, Hawkins PN, Gillmore JD. Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variant. Eur Heart J 2012; 33: 1120-1127.
22. Authors/Task Force members Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, Hagege AA, Lafont A, Limongelli G, Mahrholdt H, McKenna WJ, Mogensen J, Nihoyannopoulos P, Nistri S, Pieper PG, Pieske B, Rapezzi C, Rutten FH, Tillmanns C, Watkins H. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 2014; 35: 2733-2779.
23. Vrana JA, Gamez JD, Madden BJ, Theis JD, Bergen HR, 3rd, Dogan A. Classification of amyloidosis by laser microdissection and mass spectrometrybased proteomic analysis in clinical biopsy specimens. Blood 2009; 114: 4957-4959.